Patients receiving carbon-ion radiotherapy for primary lung cancer or metastatic lung tumors
Conditions
Interventions
Pulmonary function tests at approximately 3, 6, and 12 months after carbon-ion radiotherapy
Sponsors
National Institutes for Quantum Science and Technology QST hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients scheduled to undergo carbon-ion radiotherapy for primary lung cancer or metastatic lung tumors between the date of institutional approval and December 31, 2029, OR patients who have provided consent for the existing study at our institution (N25-013: A prospective observational study evaluating changes in pulmonary function following carbon-ion radiotherapy for lung tumors), provided they are capable of giving written informed consent for this study. 2. Patients aged 18 years or older at the time of informed consent (regardless of gender). 3. Patients who are scheduled to visit our institution for follow-up for at least 1 year after the completion of treatment. 4. Patients judged by an investigator or attending physician to be capable of understanding the informed consent document.
Exclusion criteria
Exclusion criteria: Patients judged by an investigator or attending physician to be ineligible for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Absolute and percentage changes in pulmonary function before and after carbon-ion radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between changes in pulmonary function and factors including the occurrence of adverse events and dosimetric parameters | — |
Countries
Japan
Contacts
Public ContactRyo Karita
National Institutes for Quantum Science and Technology QST hospital Section of Head, Neck and Thoracic Tumors, Department of Treatment and Diagnosis
Outcome results
None listed